Nath Bio-Genes Stock Screener | Share Price & Fundamental Analysis
NATHBIOGEN
Agricultural Products
Screen Nath Bio-Genes share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹157.20
▼
-3.94 (-2.45%)
Share Price BSE
₹157.40
▼
-3.60 (-2.24%)
Market Cap
₹295.78 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.44
EPS (TTM)
₹20.14
Dividend Yield
1.27%
Debt to Equity
0.19
52W High
₹173.74
52W Low
₹141.35
Operating Margin
9.00%
Profit Margin
6.25%
Revenue (TTM)
₹48.00
EBITDA
₹8.00
Net Income
₹3.00
Total Assets
₹1,026.00
Total Equity
₹644.00
Nath Bio-Genes Share Price History - Stock Screener Chart
Screen NATHBIOGEN historical share price movements with interactive charts. Analyze price trends and patterns.
Nath Bio-Genes Company Profile - Fundamental Screener
Screen Nath Bio-Genes company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NATHBIOGEN shares.
Sector
FMCG
Industry
Agricultural Products
Sub-Sector
Agricultural Products
Segment
E
ISIN
INE448G01010
Nath Bio-Genes Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen NATHBIOGEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,026 | 880 | 793 | 740 |
| Current Assets | 690 | 572 | 521 | 468 |
| Fixed Assets | 250 | 250 | 244 | 245 |
| Liabilities | ||||
| Total Liabilities | 1,026 | 880 | 793 | 740 |
| Current Liabilities | 17 | 8 | 3 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 644 | 610 | 573 | 542 |
| Share Capital | 19 | 19 | 19 | 19 |
| Reserves & Surplus | 625 | 591 | 554 | 523 |
Screen NATHBIOGEN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 288 | 56 | 37 | 32 | 244 | 44 | 34 | 23 | 235 | 45 | 25 | 22 | 209 | 28 |
| Expenses | 40 | 245 | 52 | 29 | 27 | 207 | 39 | 26 | 18 | 198 | 41 | 20 | 17 | 175 | 137 |
| EBITDA | 8 | 42 | 5 | 9 | 5 | 37 | 5 | 8 | 5 | 37 | 4 | 6 | 5 | 35 | -109 |
| Operating Profit % | 9.00% | 13.00% | 1.00% | 22.00% | 15.00% | 15.00% | 9.00% | 18.00% | 22.00% | 16.00% | 9.00% | 22.00% | 22.00% | 16.00% | -405.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 4 | 3 | 1 | 4 | 3 | 2 | 1 | 3 | 2 | 3 | 2 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 3 | 38 | 2 | 4 | 1 | 34 | 3 | 5 | 2 | 34 | 2 | 2 | 2 | 31 | -113 |
| Tax | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 4 |
| Net Profit | 3 | 37 | 2 | 3 | 1 | 33 | 3 | 4 | 2 | 33 | 1 | 1 | 2 | 31 | -116 |
| EPS | 1.40 | 19.58 | 0.42 | 1.33 | 0.53 | 17.49 | 1.87 | 2.02 | 0.86 | 17.59 | 0.77 | 0.71 | 0.77 | 16.18 | -61.22 |
Nath Bio-Genes Cash Flow Screener - Liquidity Fundamentals
Screen NATHBIOGEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 18 | 75 | 38 | 17 |
| Investing Activities | -4 | -27 | -3 | -20 |
| Financing Activities | -2 | -8 | -2 | -22 |
| Net Cash Flow | 12 | 39 | 34 | -25 |
Screen NATHBIOGEN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% | 45.60% |
| FII Holding | 0.21% | 0.42% | 0.32% | 0.27% | 0.22% | 0.19% | 0.19% | 0.00% |
| DII Holding | 3.94% | 2.25% | 0.76% | 4.37% | 4.38% | 4.37% | 4.37% | 4.62% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.94% | 32.98% | 33.78% | 32.25% | 32.43% | 31.54% | 31.75% | 30.17% |
| Other Holding | 18.31% | 18.76% | 19.54% | 17.51% | 17.39% | 18.31% | 18.09% | 19.62% |
| Shareholder Count | 34,911 | 34,207 | 34,122 | 35,132 | 35,834 | 35,423 | 35,056 | 33,960 |
Nath Bio-Genes Dividend Screener - Share Yield Analysis
Screen NATHBIOGEN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.00 | 1.28% |
| 2024-March | ₹2.00 | 1.37% |
| 2023-March | ₹2.00 | 1.15% |
| 2022-March | ₹2.00 | 1.43% |
| 2021-March | ₹2.00 | 0.94% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Nath Bio-Genes Index Membership - Market Screener Classification
Screen NATHBIOGEN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Nath Bio-Genes Market Events Screener - Corporate Actions
Screen NATHBIOGEN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -3.99% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 12.38% |
| 2025-08-14 | 2025-08-14 | Dividend | ₹ 2.00 /share | 11.66% |
| 2025-07-11 | 2025-07-11 | Quarterly Result Announcement | NA | 7.96% |
| 2025-04-29 | 2025-04-29 | Quarterly Result Announcement | NA | -6.81% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | 0.03% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -3.86% |
| 2024-08-17 | 2024-08-17 | Annual General Meeting | NA | 8.77% |
| 2024-08-09 | 2024-08-09 | Dividend | ₹ 2.00 /share | 12.01% |
| 2024-03-12 | 2024-03-12 | Extraordinary General Meeting | NA | -11.30% |
| 2023-07-04 | 2023-06-30 | Dividend | ₹ 2.00 /share | 12.03% |
| 2022-06-23 | 2022-06-25 | Dividend | ₹ 2.00 /share | -16.63% |
| 2021-08-18 | 2021-08-22 | Dividend | ₹ 2.00 /share | -24.60% |
Nath Bio-Genes Competitors Screener - Peer Comparison
Screen NATHBIOGEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| LT Foods | 13,440 | 21.00 | 8,770 | 12.12% | 612 | 40.99 |
| KRBL | 9,094 | 14.88 | 5,655 | 3.17% | 476 | 48.76 |
| Gujarat Ambuja Exports | 6,218 | 29.81 | 4,695 | -7.42% | 249 | 71.28 |
| Kaveri Seed Company | 4,957 | 16.58 | 1,251 | 3.28% | 282 | 48.72 |
| Trualt Bioenergy | 3,550 | 22.33 | 1,969 | 53.77% | 147 | 40.57 |
| GRM Overseas | 2,991 | 43.82 | 1,374 | 2.17% | 61 | 54.91 |
| Sanstar | 1,784 | 26.17 | 1,082 | -10.58% | 67 | 60.44 |
| Chaman Lal Setia Exports | 1,352 | 13.95 | 1,504 | 10.16% | 103 | 53.51 |
| Bombay Super Hybrid Seeds | 1,129 | 40.08 | 362 | 40.17% | 26 | 49.84 |
| Avt Natural Products | 1,026 | 16.69 | 572 | 8.00% | 48 | 48.88 |
Nath Bio-Genes Company Announcements - News Screener
Screen NATHBIOGEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Closure of Trading Window | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Financial Results As On 30Th September 2025 | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-10 | Intimation Of Earning Conference Call | View |
| 2025-11-06 | Board Meeting Intimation for Approval Of Financial Results As On 30Th Sept 2025 | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-08-22 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-07-31 | Reg. 34 (1) Annual Report. | View |
| 2025-07-31 | Thursday 14Th August 2025 | View |
| 2025-07-31 | Friday 22Nd August 2025 | View |
| 2025-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-07-11 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-07-11 | Unaudited Financial Results As On 30Th June 2025. | View |
| 2025-07-04 | Board Meeting Intimation for Approval Of Unaudited Financial Results For The 30Th June 2025 | View |
| 2025-07-03 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-06-27 | Closure of Trading Window | View |
| 2025-06-11 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | View |
| 2025-06-03 | Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate | View |